| Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial O Hermine, X Mariette, PL Tharaux, M Resche-Rigon, R Porcher, ... JAMA internal medicine 181 (1), 32-40, 2021 | 885 | 2021 |
| Pulmonary arterial hypertension in patients treated by dasatinib D Montani, E Bergot, S Günther, L Savale, A Bergeron, A Bourdin, ... Circulation 125 (17), 2128-2137, 2012 | 750 | 2012 |
| Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin. O Sitbon, F Brenot, A Denjean, A Bergeron, F Parent, R Azarian, P Herve, ... American journal of respiratory and critical care medicine 151 (2), 384-389, 1995 | 367 | 1995 |
| The prognosis of acute respiratory failure in critically ill cancer patients É Azoulay, G Thiéry, S Chevret, D Moreau, M Darmon, A Bergeron, ... Medicine 83 (6), 360-370, 2004 | 356 | 2004 |
| Obliterative bronchiolitis AF Barker, A Bergeron, WN Rom, MI Hertz New England journal of medicine 370 (19), 1820-1828, 2014 | 317 | 2014 |
| Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial PL Tharaux, G Pialoux, A Pavot, X Mariette, O Hermine, M Resche-Rigon, ... The Lancet Respiratory Medicine 9 (3), 295-304, 2021 | 275 | 2021 |
| Cytokine patterns in tuberculous and sarcoid granulomas: correlations with histopathologic features of the granulomatous response. A Bergeron, M Bonay, M Kambouchner, D Lecossier, M Riquet, P Soler, ... Journal of immunology (Baltimore, Md.: 1950) 159 (6), 3034-3043, 1997 | 263 | 1997 |
| Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF‐β and IL-10 A Bergeron, P Soler, M Kambouchner, P Loiseau, B Milleron, D Valeyre, ... European Respiratory Journal 22 (1), 69-76, 2003 | 246 | 2003 |
| Clinical characteristics and prognostic factors of pulmonary MALT lymphoma R Borie, M Wislez, G Thabut, M Antoine, A Rabbat, LJ Couderc, I Monnet, ... European Respiratory Journal 34 (6), 1408-1416, 2009 | 245 | 2009 |
| Lung abnormalities after dasatinib treatment for chronic myeloid leukemia: a case series A Bergeron, D Réa, V Levy, C Picard, V Meignin, J Tamburini, ... American journal of respiratory and critical care medicine 176 (8), 814-818, 2007 | 240 | 2007 |
| Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients A Alanio, G Desoubeaux, C Sarfati, S Hamane, A Bergeron, E Azoulay, ... Clinical microbiology and infection 17 (10), 1531-1537, 2011 | 226 | 2011 |
| Clinical picture of Pneumocystis jiroveci pneumonia in cancer patients G Bollée, C Sarfati, G Thiéry, A Bergeron, S de Miranda, J Menotti, ... Chest 132 (4), 1305-1310, 2007 | 222 | 2007 |
| Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of … L Millon, R Herbrecht, F Grenouillet, F Morio, A Alanio, V Letscher-Bru, ... Clinical Microbiology and Infection 22 (9), 810. e1-810. e8, 2016 | 220 | 2016 |
| Polymerase chain reaction for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates E Azoulay, A Bergeron, S Chevret, N Bele, B Schlemmer, J Menotti Chest 135 (3), 655-661, 2009 | 214 | 2009 |
| Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients J Camuset, H Nunes, MC Dombret, A Bergeron, P Henno, B Philippe, ... Chest 131 (5), 1435-1441, 2007 | 205 | 2007 |
| CD24hiCD27+ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease A de Masson, JD Bouaziz, H Le Buanec, M Robin, A O’Meara, N Parquet, ... Blood, The Journal of the American Society of Hematology 125 (11), 1830-1839, 2015 | 182 | 2015 |
| The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies A Bergeron, R Porcher, A Sulahian, C de Bazelaire, K Chagnon, ... Blood, The Journal of the American Society of Hematology 119 (8), 1831-1837, 2012 | 166 | 2012 |
| Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL) G Maschmeyer, J De Greef, SC Mellinghoff, A Nosari, ... Leukemia 33 (4), 844-862, 2019 | 161 | 2019 |
| Long‐term outcomes among participants in the WEGENT trial of remission‐maintenance therapy for granulomatosis with polyangiitis (Wegener's) or microscopic polyangiitis X Puéchal, C Pagnoux, É Perrodeau, M Hamidou, JJ Boffa, X Kyndt, ... Arthritis & rheumatology 68 (3), 690-701, 2016 | 142 | 2016 |
| Use and Limits of (1-3)-β-d-Glucan Assay (Fungitell), Compared to Galactomannan Determination (Platelia Aspergillus), for Diagnosis of Invasive Aspergillosis A Sulahian, R Porcher, A Bergeron, S Touratier, E Raffoux, J Menotti, ... Journal of clinical microbiology 52 (7), 2328-2333, 2014 | 141 | 2014 |
